Furthermore, in cultured mast cells, pro-inflammatory cytokine CCL5 was shown to reduce the expression of TLR2 [30], suggesting TLR2 transcription downregulation in subgroups of SMA patients due to the enhanced CCL transcription as observed for the same patient subgroups. This evidence concerns the gene CCL5 and proximal spinal muscular atrophy.